Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 24, 2015
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - May 24, 2015

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/24/15 - Amarantus Effects Capital Restructuring in Anticipation of National Exchange Listing [Jerusalem Post (Israel)]
-Amarantus BioSciences Holdings, Inc., a biotechnology company focused on developing therapeutic and diagnostic products for neurological disorders and orphan indications, announced that it has implemented a 1- for-150 reverse stock split of its common stock. In addition, we believe the potential addition of the clinical-stage orphan candidate ESS,
5/24/15 - Baxter Secures U.S. FDA Approval for 0.9% Sodium Chloride Injection, USP from Sabinanigo, Spain, Facility for the U.S. Market [Professional Services Close - Up]
Baxter International reported that the U.S. Food and Drug Administration has approved the company's supplemental drug application to establish its Sabinanigo, Spain, facility as an approved manufacturing site for 0.9 percent Sodium Chloride Injection, USP, for the U.S. market. In a release, the Company noted that the approval includes product prese
5/24/15 - Five-Year Follow-Up Study Further Supports Effectiveness and Safety of the Essure Procedure as a Non-Surgical, Non-Hormonal Option for Permanent...
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Bayer HealthCare announced that a study published online this week in The Journal of Minimally Invasive Gynecology reinforces findings from previous clinical studies that support the effectiveness and safety of the Essure inserts and procedure for hysteroscopic sterilizatio
5/24/15 - Kolltan Pharmaceuticals' Dr. Joseph Schlessinger Tapped for Medicine Maker Power List 2015 [Professional Services Close - Up]
Kolltan Pharmaceuticals recently reported that Joseph Schlessinger, Ph.D., Chairman of the Department of Pharmacology and the William H. Prusoff Professor at Yale University School of Medicine, as well as founding director of Yale's Cancer Biology Institute and co-founder of Kolltan, has been named one of the top 100 most influential people in drug
5/24/15 - Pharmacists Launch Company to Sanitise Drug Distribution
As a step towards sanitizing the chaotic drug distribution in the country, the Pharmaceutical Society of Nigeria has at last floated a limited liability company, UltraLogistics, that would operate a modern mega distribution network. At the official launch of the company profile and private placement memorandum recently held in Lagos, President of t
5/23/15 - 'Right to try' bills would let dying Californians use experimental drugs [The Sacramento Bee]
The right hand he used to play basketball in college and then combat fires near Sacramento and Modesto for nearly three decades has withered and rests, immobilized, in a splint. Part of a growing movement dubbed "right to try," the legislation would allow Californians with fatal diseases to petition pharmaceutical companies directly for experimenta
5/23/15 - ADMA Biologics to Present at the 2015 Marcum MicroCap Conference [National News Agency (Lebanon)]
-ADMA Biologics, Inc., a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, announced that it will present at the 2015 Marcum MicroCap Conference on May 28, 2015 in New York City at the Grand Hyatt New York.
5/23/15 - Advaxis to Present at the Jefferies 2015 Global Healthcare Conference [Daily Star, The (Lebanon)]
-Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, announced today that Daniel J. O'Connor, President and Chief Executive Officer of Advaxis, will present at the 2015 Jefferies Global Healthcare Conference being held June 1-4, 2015 in New York, NY. Advaxis entered into a clinical trial collaboration with MedIm
5/23/15 - ALS Therapy Development Institute Expands Research Team with Four New Hires [Kuwait News Agency]
-The ALS Therapy Development Institute expanded its Kendall Square team recently when it filled four new research positions with scientists and technicians, all of whom are highly qualified in their specific fields. Calo has undertaken successful internships as a researcher and laboratory technician in academia and the pharmaceutical industry,...
5/23/15 - Atyr Pharma Inc. Files SEC Form CERTNAS, Certification By The National Association of Securities Dealers Automated Quotation Approving Securities For...
Atyr Pharma Inc. Files SEC Form CERTNAS, Certification By The National Association of Securities Dealers Automated Quotation Approving Securities For Listing. By a News Reporter-Staff News Editor at Investment Weekly News According to news reporting originating from Washington, D.C., by VerticalNews journalists, a U.S. Securities and Exchange...
5/23/15 - Galena Biopharma to Present GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial Data at the European Hematology Association 20th Congress [Daily Tribune (Bahrain)]
-Galena Biopharma, Inc., a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced that data from the Company's Phase 2 clinical trial of GALE-401, or Anagrelide Controlled Release, will be presented at the upcoming.
5/23/15 - In Violation of Patents And Health Law Regulations, Mexican Supreme Court lined On The requisite Legal Standing to enquiry Marketing Authorizations [FARS News Agency]
The Mexican Supreme Court by the end of 2013, published a landmark decision that now is publically obtainable that certainly will impact the legal framework of the Pharmaceutical Industry in Mexico. The Regulatory Agency in charge of granting the marketing authorizations in Mexico granted a generic company an approval for the same product as...
5/23/15 - Strides Arcolab to buy Aspen\'s generic pharma [India Infoline News Service]
Strides Arcolab announced that Strides Pharma Global Pte. Ltd, Singapore and Strides (Australia) Pharma Pty Ltd, Australia, both wholly owned subsidiaries of Strides Arcolab have signed definitive agreements with certain wholly owned subsidiaries of Aspen Pharmacare Holdings Limited, a company listed on the Johannesburg Stock Exchange (Aspen), to a
5/23/15 - WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition
By a News Reporter-Staff News Editor at Marketing Weekly News The fairness of the proposed acquisition of Synageva Biopharma Corp. by Alexion Pharmaceuticals, Inc. is being investigated by WeissLaw LLP, a national class action, shareholder rights law firm, for possible breaches of fiduciary duty and other violations of law by the Board of Directo
5/23/15 - Xenon Pharmaceuticals Appoints Steven Gannon to Its Board of Directors [Qatar Tribune]
-Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, today announced that Steven Gannon has been appointed to its Board of Directors, where he will also serve on the Company's Audit Committee. His past executive experience includes serving as Chief Financial Officer, Senior Vice President of Finance, and Treasurer at Aptalis Pha
5/22/15 - 2015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China
Research and Markets has announced the addition of the "Latest Regulations on Pharmaceutical International Multi-Center Clinical Trials in China" report to their offering. This is first time in history, Chinese pharmaceutical authorities officially issued a guidance on international multi-center clinical trials of drugs in China, which has begun
5/22/15 - AB Science: Independent Publication from experts highlights the potential of masitinib in Alzheimer's disease [National News Agency (Lebanon)]
-AB Science SA, a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors, today announces the publication of a wide-ranging independent review article entitled' Masitinib for the treatment of mild to moderate Alzheimer's disease' in the peer-reviewed journal Expert Review of...
5/22/15 - AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that interim chief executive officer Howie Rosen will be presenting at Jefferies 2015 Healthcare Conference and chief financial officer Tim...
5/22/15 - Acucela Nominates Shintaro Asako to Its Board of Directors [Global Data Point]
Before becoming CEO in 2013, Mr. Asako was the Chief Financial Officer of DeNA West and before that, served as CFO of MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange. He also has experience in the management of U.S. biopharmaceutical companies and publicly listed com
5/22/15 - ADMA Biologics to Present at the 2015 Marcum MicroCap Conference
ADMA Biologics, Inc., a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, announced that it will present at the 2015 Marcum MicroCap Conference on May 28, 2015 in New York City at the Grand Hyatt New York.
5/22/15 - Advaxis to Present at the Jefferies 2015 Global Healthcare Conference
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, announced today that Daniel J. O'Connor, President and Chief Executive Officer of Advaxis, will present at the 2015 Jefferies Global Healthcare Conference being held June 1-4, 2015 in New York, NY. Advaxis entered into a clinical trial collaboration with MedI
5/22/15 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry: Notification of a Health...
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry: Notification of a Health Claim or Nutrient Content Claim Based on an Authoritative Statement of a Scientific Body. SUMMARY: The Food and Drug Administration is announcing that a collection of information entitled, "Guidance for
5/22/15 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Requests for Inspection by an Accredited Person...
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Requests for Inspection by an Accredited Person Under the Inspection by Accredited Persons Program. SUMMARY: The Food and Drug Administration is announcing that a collection of information entitled "Requests for Inspection by an Accredited Person und
5/22/15 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Substances Prohibited From Use in Animal Food or...
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Substances Prohibited From Use in Animal Food or Feed. SUMMARY: The Food and Drug Administration is announcing that a collection of information entitled, "Substances Prohibited From Use in Animal Food or Feed" has been approved by the Office of Manag
5/22/15 - Amarantus Effects Capital Restructuring in Anticipation of National Exchange Listing
Amarantus BioSciences Holdings, Inc., a biotechnology company focused on developing therapeutic and diagnostic products for neurological disorders and orphan indications, announced that it has implemented a 1- for-150 reverse stock split of its common stock. In addition, we believe the potential addition of the clinical-stage orphan candidate ESS
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2015 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Pharmacy Spanish
This lesson is supported by:
Hands on Spanish
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415